Influence of a safety notice issued by the Spanish Agency of Medicaments and Health Products on the use of the topical active ingredients pimecrolimus and tacrolimus;Influencia de una nota de seguridad emitida por la Agencia Española de Medicamentos y Productos Sanitarios en el uso de los principios activos tópicos pimecrolimus y tacrolimus

Pharmaceutical Care Espana

Volumn 10, Issue 2, 2008, Pages 94-96

  De Elizondo Lopez Landache I ^a   Braceras Izaguirre, L ^b  

^a Osakidetza Servicio Vasco de Salud   (Spain)

^b Gobierno Vasco ^*  (Spain)

Author keywords

Atopic dermatitis; Pimecrolimus; Safety notice; Tacrolimus

Indexed keywords

PIMECROLIMUS; TACROLIMUS;

ATOPIC DERMATITIS; DISEASE ASSOCIATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HUMAN; INFORMATION SYSTEM; PHARMACY; PRESCRIPTION; PUBLIC HEALTH SERVICE; SEASONAL VARIATION; SHORT SURVEY;

EID: 77950034582     PISSN: None     EISSN: 11396202     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (0)